Curriculum
- 6 Sections
- 31 Lessons
- 2 Days
Expand all sectionsCollapse all sections
- Introduction to Competitive Intelligence (CI)7
- 1.0Definition and importance of CI in pharma product development.
- 1.1Key CI frameworks: Porter’s Five Forces, SWOT analysis, PESTLE analysis.
- 1.2Importance of CI in product strategy.
- 1.3Case Study: Leveraging CI for market entry.
- 1.4Distinction between competitive intelligence, market research, and business intelligence.
- 1.5Regulatory and ethical considerations in CI (compliance with laws like GDPR and FDA regulations).
- 1.6Group discussion on challenges faced in gathering competitor data within the pharma sector.
- Competitive Landscapes Analysis6
- 2.0Mapping competitors and understanding their positioning.
- 2.1Sources of CI in pharma: Clinical trial databases, patents, regulatory submissions, and publications.
- 2.2Tools and software for data mining (e.g., Cortellis, PubMed, IQVIA).
- 2.3Deep dive into competitive benchmarking.
- 2.4Case study: How a leading pharma company used CI to launch a first-to-market drug.
- 2.5Interactive Simulation: Analyze a mock competitor’s product development pipeline using CI tools.
- Trends and Jargons in CI4
- Strategic Decision-Making with CI6
- 4.0Translating CI insights into actionable strategies.
- 4.1Product positioning, go/no-go decision-making, and risk mitigation strategies.
- 4.2Evaluating competitor strengths and weaknesses through CI metrics.
- 4.3Scenario planning and forecasting market dynamics.
- 4.4Case Study: Success stories of pharma firms leveraging CI for strategic wins.
- 4.5Interactive Exercise: Simulate a “war room” exercise, crafting a strategy to counter a competitor’s new product launch.
- CI Tools, Techniques, and Ethical Considerations5
- 5.0Advanced CI tools: Predictive analytics, patent landscaping, and pipeline intelligence.
- 5.1Techniques: Reverse engineering competitor tactics, leveraging open-source intelligence (OSINT).
- 5.2Ethical dilemmas in CI gathering and resolving grey areas.
- 5.3Case Study: A look into the implications of ethical violations in CI.
- 5.4Breakout session: Ethical dilemma resolution exercises.
- Competitive Intelligence as a Value Driver4
Integrating CI into the lifecycle of pharma product development.
Prev